Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

FDA analyses of survival in older adults with metastatic non-small cell lung cancer in controlled trials of PD-1/PD-L1 blocking antibodies.

Marur S, Singh H, Mishra-Kalyani P, Larkins E, Keegan P, Sridhara R, Blumenthal GM, Pazdur R.

Semin Oncol. 2018 Aug;45(4):220-225. doi: 10.1053/j.seminoncol.2018.08.007. Epub 2018 Oct 31. Review.

PMID:
30391014
2.

Developing Telemental Health Partnerships Between State Medical Schools and Federally Qualified Health Centers: Navigating the Regulatory Landscape and Policy Recommendations.

Fortney JC, Veith RC, Bauer AM, Pfeiffer PN, Valenstein M, Pyne JM, Dalack GW, Kramer TL, Ferro LJ, Metzger K, Shore JH, Carlo AD, Coates S, Ward-Jones S, Larkins E, Hafer E, Shushan S, Weaver DL, Unützer J.

J Rural Health. 2019 Jun;35(3):287-297. doi: 10.1111/jrh.12323. Epub 2018 Oct 4.

PMID:
30288797
3.

FDA Approval Summary: Dabrafenib and Trametinib for the Treatment of Metastatic Non-Small Cell Lung Cancers Harboring BRAF V600E Mutations.

Odogwu L, Mathieu L, Blumenthal G, Larkins E, Goldberg KB, Griffin N, Bijwaard K, Lee EY, Philip R, Jiang X, Rodriguez L, McKee AE, Keegan P, Pazdur R.

Oncologist. 2018 Jun;23(6):740-745. doi: 10.1634/theoncologist.2017-0642. Epub 2018 Feb 7.

4.

FDA Benefit-Risk Assessment of Osimertinib for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor T790M Mutation.

Odogwu L, Mathieu L, Goldberg KB, Blumenthal GM, Larkins E, Fiero MH, Rodriguez L, Bijwaard K, Lee EY, Philip R, Fan I, Donoghue M, Keegan P, McKee A, Pazdur R.

Oncologist. 2018 Mar;23(3):353-359. doi: 10.1634/theoncologist.2017-0425. Epub 2017 Dec 14.

5.

FDA Approval Summary: Pembrolizumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma with Disease Progression on or After Platinum-Containing Chemotherapy.

Larkins E, Blumenthal GM, Yuan W, He K, Sridhara R, Subramaniam S, Zhao H, Liu C, Yu J, Goldberg KB, McKee AE, Keegan P, Pazdur R.

Oncologist. 2017 Jul;22(7):873-878. doi: 10.1634/theoncologist.2016-0496. Epub 2017 May 22.

6.

FDA Approval: Alectinib for the Treatment of Metastatic, ALK-Positive Non-Small Cell Lung Cancer Following Crizotinib.

Larkins E, Blumenthal GM, Chen H, He K, Agarwal R, Gieser G, Stephens O, Zahalka E, Ringgold K, Helms W, Shord S, Yu J, Zhao H, Davis G, McKee AE, Keegan P, Pazdur R.

Clin Cancer Res. 2016 Nov 1;22(21):5171-5176. Epub 2016 Jul 13.

7.

Telemedicine with clinical decision support for critical care: a systematic review.

Mackintosh N, Terblanche M, Maharaj R, Xyrichis A, Franklin K, Keddie J, Larkins E, Maslen A, Skinner J, Newman S, De Sousa Magalhaes JH, Sandall J.

Syst Rev. 2016 Oct 18;5(1):176. Review.

8.

Clinician Perspectives on Current Issues in Lung Cancer Drug Development.

Waqar SN, Bonomi PD, Govindan R, Hirsch FR, Riely GJ, Papadimitrakopoulou V, Kazandjian D, Khozin S, Larkins E, Dickson DJ, Malik S, Horn L, Ferris A, Shaw AT, Jänne PA, Mok TS, Herbst R, Keegan P, Pazdur R, Blumenthal GM.

J Thorac Oncol. 2016 Sep;11(9):1387-96. doi: 10.1016/j.jtho.2016.05.009. Epub 2016 Jul 9. Review.

9.

U.S. Food and Drug Administration Approval Summary: Ramucirumab for the Treatment of Metastatic Non-Small Cell Lung Cancer Following Disease Progression On or After Platinum-Based Chemotherapy.

Larkins E, Scepura B, Blumenthal GM, Bloomquist E, Tang S, Biable M, Kluetz P, Keegan P, Pazdur R.

Oncologist. 2015 Nov;20(11):1320-5. doi: 10.1634/theoncologist.2015-0221. Epub 2015 Oct 7.

10.

A Phase II Study of Sorafenib Combined With Cetuximab in EGFR-Expressing, KRAS-Mutated Metastatic Colorectal Cancer.

Do K, Cao L, Kang Z, Turkbey B, Lindenberg ML, Larkins E, Holkova B, Steinberg SM, Raffeld M, Peer CJ, Figg WD, Eugeni M, Jacobs P, Choyke P, Wright JJ, Doroshow JH, Kummar S.

Clin Colorectal Cancer. 2015 Sep;14(3):154-61. doi: 10.1016/j.clcc.2015.02.007. Epub 2015 Mar 7.

11.

The turn team: a novel strategy for reducing pressure ulcers in the surgical intensive care unit.

Still MD, Cross LC, Dunlap M, Rencher R, Larkins ER, Carpenter DL, Buchman TG, Coopersmith CM.

J Am Coll Surg. 2013 Mar;216(3):373-9. doi: 10.1016/j.jamcollsurg.2012.12.001. Epub 2013 Jan 11.

PMID:
23313540
12.

Losing ground: NIH funding to New York State researchers.

Sturman LS, Sorin MD, Larkins E, Cavanagh KA, DeBuono BA.

Bull N Y Acad Med. 1997 Summer;74(1):6-14. No abstract available.

13.

Monolayer-resolved x-ray-excited Auger-electron diffraction from single-plane emission in GaAs.

Seelmann-Eggebert M, Fasel R, Larkins EC, Osterwalder J.

Phys Rev B Condens Matter. 1993 Oct 15;48(16):11838-11845. No abstract available.

PMID:
10007523

Supplemental Content

Loading ...
Support Center